Immunogenicity and Safety of the Spikevax (R) (Moderna) mRNA SARS-CoV-2 Vaccine in Patients with Primary Humoral Immunodeficiency

Kralickova, P; Jankovicova, K; Sejkorova, I; Soucek, O; Koprivova, K; Drahosova, M; Andrys, C; Krejsek, J

Kralickova, P (通讯作者),Univ Hosp Hradec Kralove, Inst Clin Immunol & Allergy, Hradec Kralove, Czech Republic.;Kralickova, P (通讯作者),Charles Univ Prague, Fac Med, Hradec Kralove, Czech Republic.

INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2022; 183 (12): 1297

Abstract

Introduction: Reports on the immunogenicity and efficacy of the Spikevax (R) vaccine against SARS-CoV-2 in immunodeficient patients are still scarce. ......

Full Text Link